G108

CAS No. 2369750-66-1

G108( —— )

Catalog No. M36299 CAS No. 2369750-66-1

G108 is an inhibitor of human cGAS and is used in the study of autoimmune diseases associated with human cGAS.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1074 In Stock
10MG 1454 In Stock
25MG 2157 In Stock
50MG 2762 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    G108
  • Note
    Research use only, not for human use.
  • Brief Description
    G108 is an inhibitor of human cGAS and is used in the study of autoimmune diseases associated with human cGAS.
  • Description
    G108 is an inhibitor of human cGAS and is used in the study of autoimmune diseases associated with human cGAS.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    cGAS
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2369750-66-1
  • Formula Weight
    365.21
  • Molecular Formula
    C16H14Cl2N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(N1CC=2C=3C(=CC(Cl)=C(Cl)C3NC2CC1)C=4C=NNC4)CO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • D-Saccharic acid pot...

    D-Saccharic acid potassium salt is a compound formed from oxidizing sugars which can be used to test for the presence of hepatic enzyme induction. Studies indicate that D-glucuronolactone dehydrogenase oxidizes D-Saccharic acid potassium salt into D-glucaro-l4;63-dilactone.

  • Biotin-MBP Derivatiz...

    Biotin-MBP Derivatized Peptide

  • N'-Methylnicotinamid...

    N-methylnicotinamide is a metabolite of niacin (or nicotinamide) and is commonly found in human urine. However low levels of urinary excretion of N-methylnicotinamide indicates niacin deficiency. In patients with liver cirrhosis nicotinamide methylation is increased leading to a rise in urinary N-methylnicotinamide. N-methylnicotinamide has been found to be a microbial metabolite.